Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, FDA Make Deal; Firm Resumes Selling Neonatal Dx Kits

NEW YORK, Feb. 16 (GenomeWeb News) - PerkinElmer "has reached agreement" with the US Food and Drug Administration, and will resume making and shipping neonatal diagnostic kits at its Norton, Ohio facility, the company said late last week.

Under the agreement, which enables PerkinElmer to immediately restart   producing and shipping the chemistry and isoelectric-focusing kits, the company will submit the products to additional undisclosed testing, and offer additional labeling advising proper use.

As GenomeWeb News reported Feb. 5, the FDA had seized the PerkinElmer kits because they were "adulterated under the federal Food, Drug, and Cosmetic Act." In the  statement, the FDA said that the US District Court for the Northern District of Ohio had given it a warrant to seize the kits in PerkinElmer's Norton facility, and that the US Marshal's service had executed the warrant Feb. 4.

The FDA said the kits, which are used to screen for genetic diseases such as sickle cell anemia and multiple sclerosis, "were not manufactured in accordance with FDA's good manufacturing practice quality system regulation."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.